Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma
Join experts from Benchling and AbbVie, as they dive into Benchling's 2024 State of Tech in Biopharma report and share insights into the current tech landscape, AI readiness, and strategies for digital transformation shaping large and small biopharma.
Mohit Agnihotri, Sr. Director, Development Sciences Data & Digital Strategy at AbbVie, will discuss the critical role of change management and cultural mindset shifts needed for successful AI adoption in large biopharma.
Lauren DeVos, Head of Strategy at Benchling, will highlight pivotal strategies for digital transformation, focusing on R&D data platforms, robotics, SaaS, and connected instruments to streamline workflows.
Jonathan Grinstein, North American Editor at Inside Precision Medicine, will leverage over a decade of biotech experience to guide the discussion and Q&A throughout the webinar.
